Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
15% lidocaine/5 MG/ML 0.02% estradiol compound cream
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		----1件: 226 💬
250 patients will have A free choice between filgotinib and anti TNF1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
3After surgery FOR crohn'S disease, eligible patients will BE randomized 1:1 TO receive oral EXL01----1件: 96 💬
4Alkalinized lidocaine-heparin
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		----1件: 226 💬
5ALL patients IN THE study will BE treated with ocrelizumab----1件: 13 💬
6ALS patients epidemiological caracterization----1件: 2 💬
7ALS patients genetic characterization----1件: 2 💬
8Asthma patients----1件: 299 💬
9AT-home natalizumab treated MS patient----1件: 13 💬
10Belimumab IN SLE patients / rituximab IN RA patients1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 46, 49 💬
11Best medical treatment (BMT): adjustment OF THE dopaminergic medication and NON-dopaminergic therapy customized FOR each patient according TO THE latest published consensus group recommendations----1件: 6 💬
12Biil 284 BS, high dose, adult patients----1件: 299 💬
13Biil 284 BS, high dose, pediatric patients----1件: 299 💬
14Biil 284 BS, LOW dose, adult patients----1件: 299 💬
15Biil 284 BS, LOW dose, pediatric patients----1件: 299 💬
16Biil 284 BS, medium dose, adult patients----1件: 299 💬
17Biil 284 BS, medium dose, pediatric patients----1件: 299 💬
18Bladder instillation with heparin/ lidocaine
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		----1件: 226 💬
19Blood drawing IN patients with WAS----1件: 65 💬
20Bpan patients----1件: 121 💬
21Buprenorphine transdermal patch1件: Buprenorphine2件: Buprenorphine hydrochloride ,
Buprenorphine 💬 		2件: OPRK1,
OPRM1 💬 		5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 46 💬
22CELL-based therapy OF autologous adipose derived regenerative cells transplanted intraspinally and intrathecally IN ALS patients----1件: 2 💬
23CF patients with A G551D mutation and treated with ivacaftor----1件: 299 💬
24Clinical characteristics OF AMS patients----1件: 17 💬
25Cryopreserved EFS-ADA LV transduced patient CD34+ cells----1件: 65 💬
26Cryopreserved G2scid lentiviral vector transduced patient CD34+ cells----1件: 65 💬
27Dietary pattern----1件: 46 💬
28Dietary patterns----1件: 46 💬
29Dietary supplement FOR PKU patients----1件: 240 💬
30EX vivo culture and transduction OF THE patient'S autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL20- 4I-EF1alpha-hgammac-OPT vector----1件: 65 💬
31EX-vivo approach concerning 25 patients----3件: 102, 121, 299 💬
32Exelon 4.6 MG/24 H transdermal patch1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
33Exelon 9.5 MG/24 H transdermal patch1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
34Exelon path transdermal1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
35Feasibility OF BETA-hydroxybutyrate supplementation TO reduce inflammation IN patients with crohn'S----2件: 96, 97 💬
36Fentanyl transdermal patch1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 46 💬
37Gamma-secretase/notch signalling pathway inhibitor RO4929097----1件: 74 💬
38Genetic profiling OF ALL eligible patients----1件: 278 💬
39Golimumab 50 MG IN patients <80 KG and golimumab 100 MG IN patients >80 KG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
40Group 1 OF patients will receive adalimumab while group 1 will receive ustekinumab----1件: 97 💬
41Heparin & alkalinized lidocaine bladder instillation
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		1件: Heparin2件: Heparin sodium ,
Heparin calcium 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 226 💬
42Histone acetylation profiles OF cells OF SRT patients with crebbp mutations----1件: 102 💬
43IN-vitro approach concerning 25 patients----3件: 102, 121, 299 💬
44Intervention FOR incipient patients AT LOW risk OF disease progression----1件: 66 💬
45Intervention FOR patients AT high risk OF disease progression----1件: 66 💬
46Lidocaine
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		1件: Lidocaine3件: Lidocaine (LIDOCAINE 5% PATCH, LIDOCAINE PATCH),
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬10件: 6, 13, 22, 46, 86, 107, 168, 226, 231, 256 💬
47Lidocaine 1% injectable solution
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		1件: Lidocaine3件: Lidocaine (LIDOCAINE 5% PATCH, LIDOCAINE PATCH),
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬2件: 34, 168 💬
48Lidocaine 2% without vessel constrictor
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		1件: Lidocaine3件: Lidocaine (LIDOCAINE 5% PATCH, LIDOCAINE PATCH),
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 51 💬
49Lidocaine hydrochloride
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		1件: Lidocaine3件: Lidocaine (LIDOCAINE 5% PATCH, LIDOCAINE PATCH),
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 6 💬
50Lidocaine hydrochloride, injectable
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		1件: Lidocaine3件: Lidocaine (LIDOCAINE 5% PATCH, LIDOCAINE PATCH),
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
51Lidocaine IV
(LIDOCAINE 5% PATCH, LIDOCAINE PATCH)		1件: Lidocaine3件: Lidocaine (LIDOCAINE 5% PATCH, LIDOCAINE PATCH),
Lidocaine hydrochloride ,
Lidocaine hydrochloride monohydrate 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 298 💬
52Long term follow UP IN ALL patients WHO received SAR422459 IN previous study TDU13583----1件: 301 💬
53Loxoprofen sodium hydrogel patch1件: Loxoprofen1件: Loxoprofen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
54Neupro 2 MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
55Neupro 2MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
56Neupro 2MG/24H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
57Neupro 4 MG / 24 HR. transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
58Neupro 4 MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
59Neupro 4MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
60Neupro 4MG/24H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
61Neupro 4MG/24HR transdermal patch----1件: 6 💬
62Neupro 6 MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
63Neupro 6MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
64Neupro 6MG/24H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
65Neupro 8 MG/24 H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
66Neupro 8MG/24H transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
67Nicotine patch1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬 		16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬2件: 6, 84 💬
68Nicotine transdermal patch1件: Nicotine2件: Nicotine ,
Nicotine bitartrate 💬 		16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬 		9件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Ebolavirus, Lyssavirus and Morbillivirus 💬1件: 6 💬
69Observation OF ocrelizumab AS treatment IN rrms patients----1件: 13 💬
70Observational study with patients treated with tracleer, ventavis, veletri, opsumit and/or uptravi----1件: 86 💬
71PAT----1件: 160 💬
72Patient current care----1件: 46 💬
73Patient treated with dmard----1件: 46 💬
74Patients will BE randomized TO receive EHP-101----1件: 51 💬
75Patients' existing NON-steroidal ANTI-inflammatory drug (nsaid) AT approved doses----1件: 46 💬
76Patisiran1件: Patisiran (Patisiran sodium)2件: Patisiran sodium (Patisiran sodium),
Patisiran (Patisiran) 💬 		1件: TTR 💬 1件: Thyroid hormone synthesis 💬1件: 28 💬
77PD patients H&Y=1.5-2 medications OFF----1件: 6 💬
78PD patients H&Y=1.5-2 medications ON----1件: 6 💬
79PD patients H&Y=3 medications OFF----1件: 6 💬
80PD patients H&Y=3 medications ON----1件: 6 💬
81Pilocarpine microneedle patch1件: Pilocarpine3件: Pilocarpine ,
Pilocarpine hydrochloride ,
Pilocarpine nitrate 💬 		2件: CHRM2,
CHRM3 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299 💬
82PKD patients----1件: 6 💬
83Reduced-dose conditioning regimen containing TBI IN hematopoietic stem cell transplantation treating elderly patients with aplastic anemia----1件: 60 💬
84Rituximab, observational study amon patients with active RA1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
85Rivastigmin luye transdermal patches - 4.6MG/24H----1件: 6 💬
86Rivastigmine luye transdermal patch- 9.5MG/24H1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
87Rivastigmine patch 9.5 CM21件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬1件: 6 💬
88Rivastigmine transdermal patch1件: Rivastigmine2件: Rivastigmine tartrate ,
Rivastigmine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 6, 13 💬
89Rotigotine 4MG/24HRS patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 127 💬
90Rotigotine 6MG/24HRS patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 127 💬
91Rotigotine 8MG/24HRS patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
92Rotigotine transdermal patch1件: Rotigotine1件: Rotigotine 💬 1件: DRD2 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
93Routine transdermal oestrogen patch----1件: 78 💬
94Smartpill motility system & pillcam patency capsule----1件: 299 💬
95THE effectiveness OF xeljanz IN rheumatoid arthritis patients----1件: 46 💬
96THE patients' parents have TO complete THE vineland II adaptive behavior scales scoring, THE sleep disturbance scale FOR children (sdsc) and horne & ostberg circadian typology questionnaire----1件: 149 💬
97TNF-blockers suspension IN patients with rheumatoid arthritis----1件: 46 💬
98TOP down treatment IF patient AT high risk----2件: 96, 97 💬
99Treat with lansoprazole 30 MG BID FOR 2 weeks, endoscopic examination with esophageal biopsy FOR patients with persistent symptoms----1件: 98 💬